Skip to Content

GSI 255 (Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg)

Generic Name: emtricitabine/rilpivirine/tenofovir alafenamide

Pill with imprint GSI 255 is Gray, Capsule-shape and has been identified as Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg. It is supplied by Gilead Sciences, Inc..

Odefsey is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 255

Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg GSI 255
Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg GSI 255
Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg GSI 255

Odefsey

Generic Name:
emtricitabine/rilpivirine/tenofovir alafenamide
Imprint:
GSI 255
Strength:
emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg
Color:
Gray
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Gilead Sciences, Inc.
National Drug Code (NDC):
61958-2101

Get help with Imprint Code FAQs.

More about Odefsey (emtricitabine / rilpivirine / tenofovir alafenamide)

Consumer resources

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide